搜尋結果
California Cuts Cost of Overdose-Reversal Drug by 40% in Generic Deal
Bloomberg· 4 日前... efforts to combat surging opioid-related deaths by teaming with a maker of generic< ... ...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 4 日前The FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, ...
Sandoz reaches agreement with Amgen over patent dispute
Reuters· 3 日前Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S ...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters· 9 小時前, opens new tab said on Friday it had reached a deal valued at more than $270 million to ...
Bausch Health investors are left in a holding pattern as 2 major overhangs remain unresolved
CNBC· 1 日前Bausch Health Companies on Tuesday morning reported first-quarter top- and bottom-line misses — ...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 2 日前As of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market ...
United Airlines Turns To Generative AI To Help Explain Flight Delays
Forbes· 19 小時前Every flight delay happens for a reason, but passengers don’t always get the full story. United ...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 4 日前Pfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired ...
The Blogger Turned UHNW Travel Agent
Forbes· 19 小時前Today’s top private travel agents spend months on the road, road-testing trips or meeting ...
Bayer must face US company's flea and tick drug antitrust lawsuit
Reuters· 2 日前, opens new tab must face a U.S. antitrust lawsuit accusing a former unit of the German company ...